阿奇霉素联合喜炎平治疗小儿支原体肺炎的疗效观察.docVIP

阿奇霉素联合喜炎平治疗小儿支原体肺炎的疗效观察.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
阿奇霉素联合喜炎平治疗小儿支原体肺炎的疗效观察.doc

阿奇霉素联合喜炎平治疗小儿支原体肺炎的疗效观察 梁春霞,姜秀凤,姜德华 (辽宁省普兰店市中心医院药剂科,辽宁 普兰店 116200) [摘要] 目的 评价阿奇霉素联合喜炎平注射液治疗小儿支原体肺炎的临床疗效及安全性。方法 将98例小儿支原体肺炎患儿随机分为治疗组及对照组。2组患儿均采用相同的基础治疗,治疗组再给予阿奇霉素联合喜炎平注射液静滴治疗,对照组只给与同等剂量的阿奇霉素静滴治疗。2组均连续治疗5d,停药3d后再连续治疗3d。结果 治疗组总有效率为98%,对照组总有效率为85.7%,治疗组总有效率高于对照组(P<0.05)(P均<0.01)2组治疗后肺功能均较治疗前显著改善,且治疗组改善幅度显著大于对照组(P<0.05)2组治疗后血清IL-6、IL-8、TNF-α(P均<0.01)2组不良反应发生率比较无显著性差异(P>0.05) R563.1 [文献标识码] B Observation of curative effect of Azithromycin combined with Xiyanping injection in the treatment of mycoplasma pneumonia in children Liang Chunxia, Jiang Xiufeng, JiangDehua (Liaoning Puliandian City Zhongxin Hospital Department of pharmacy, Liaoning Pulandian 116200 China) [Abstract] Objective to evaluate the clinical efficacy and safety of Azithromycin combined with Xiyanping injection in treatment of children with Mycoplasma pneumonia.Methods 98 cases of children with mycoplasma pneumonia were randomly divided into treatment group and control group. Two groups of children were given the same basic treatment. Treatment group was given extra Azithromycin combined with Xiyanping intravenous injection. The two groups were treated for continuous five days, after stopping the medicine for three days, then give another three days treatment. Results The total effective rate of treatment group was 98%, control group 85.7%, total effective rate in the treatment group is higher than in the control group (P 0.05). The treatment group in abatement time of fever, cough disappeared time, rales disappearance time, chest X-ray absorption time and hospital stay were significantly shorter than the control group (P 0.01). Pulmonary function of two groups after treatment was both improved, and the treatment group was improved significantly more than the control group (P 0.05). The serum IL-6, IL-8, TNF- α levels were also improved, and the treatment group was improved significantly more than the control group (P 0.01). Adverse reactions of two groups have no significant difference

文档评论(0)

wuyouwulu + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档